How do you design randomised trials for smaller populations? A framework
Author:
Funder
Medical Research Council
Publisher
Springer Science and Business Media LLC
Subject
General Medicine
Link
http://link.springer.com/content/pdf/10.1186/s12916-016-0722-3.pdf
Reference24 articles.
1. Gagne JJ, Thompson L, O’Keefe K, Kesselheim AS. Innovative research methods for studying treatments for rare diseases: methodological review. BMJ. 2014; 349:6802. doi: 10.1136/bmj.g6802 .
2. Rustin GJS, van der Burg MEL, Griffin CL, Guthrie D, Lamont A, Jayson GC, et al.Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial. Lancet. 2010; 376(9747):1155–63. doi: 10.1016/s0140-6736(10)61268-8 .
3. Bogaerts J, Sydes MR, Keat N, McConnell A, Benson A, Ho A, et al.Clinical trial designs for rare diseases: studies developed and discussed by the international rare cancers initiative. Eur J Cancer. 2015; 51(3):271–81. doi: 10.1016/j.ejca.2014.10.027 .
4. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al.Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976; 34(6):585–612.
5. Cook J, Hislop J, Adewuyi T, Harrild K, Altman D, Ramsay C, et al.Assessing methods to specify the target difference for a randomised controlled trial: DELTA (difference ELicitation in TriAls) review. Health Technol Assess. 2014; 18(28):1–166. doi: 10.3310/hta18280 .
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Monitoring Overall Survival in Pivotal Trials in Indolent Cancers;Statistics in Biopharmaceutical Research;2024-09-03
2. How to develop new systemic treatments in ultra-rare cancers with high unmet needs? The case of alveolar soft-part sarcoma;European Journal of Cancer;2024-05
3. Efficiency of Biomarker-Driven Clinical Trial Designs;Journal of Clinical Oncology;2024-04-20
4. Estimating the Prognostic Value of the NTRK Fusion Biomarker for Comparative Effectiveness Research in The Netherlands;Molecular Diagnosis & Therapy;2024-04-14
5. Evaluation of the multimodal DELTA therapy for adolescents with substance use disorders: an exploratory pilot trial;Frontiers in Psychiatry;2024-01-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3